- Home
- CPBI vs CRVO Comparison
CPBI vs CRVO Comparison
Compare CPBI & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPBI
- CRVO
- Stock Information
- Founded
- CPBI 2023
- CRVO 2001
- Country
- CPBI United States
- CRVO United States
- Employees
- CPBI N/A
- CRVO N/A
- Industry
- CPBI
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- CPBI
- CRVO Health Care
- Exchange
- CPBI Nasdaq
- CRVO Nasdaq
- Market Cap
- CPBI 58.1M
- CRVO 69.3M
- IPO Year
- CPBI N/A
- CRVO N/A
- Fundamental
- Price
- CPBI $14.55
- CRVO $7.22
- Analyst Decision
- CPBI
- CRVO Strong Buy
- Analyst Count
- CPBI 0
- CRVO 8
- Target Price
- CPBI N/A
- CRVO $25.57
- AVG Volume (30 Days)
- CPBI 1.3K
- CRVO 234.7K
- Earning Date
- CPBI 01-01-0001
- CRVO 05-12-2025
- Dividend Yield
- CPBI N/A
- CRVO N/A
- EPS Growth
- CPBI 29.70
- CRVO N/A
- EPS
- CPBI 1.62
- CRVO N/A
- Revenue
- CPBI $18,546,000.00
- CRVO $9,308,215.00
- Revenue This Year
- CPBI N/A
- CRVO N/A
- Revenue Next Year
- CPBI N/A
- CRVO N/A
- P/E Ratio
- CPBI $9.00
- CRVO N/A
- Revenue Growth
- CPBI 13.73
- CRVO 15.14
- 52 Week Low
- CPBI $9.96
- CRVO $1.80
- 52 Week High
- CPBI $15.50
- CRVO $22.57
- Technical
- Relative Strength Index (RSI)
- CPBI 43.62
- CRVO 35.85
- Support Level
- CPBI $14.53
- CRVO $7.51
- Resistance Level
- CPBI $14.80
- CRVO $8.59
- Average True Range (ATR)
- CPBI 0.10
- CRVO 0.50
- MACD
- CPBI -0.04
- CRVO -0.17
- Stochastic Oscillator
- CPBI 4.26
- CRVO 8.40
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.